4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001214659-19-005669
EVP of R&D and CMO acquired 105,162 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Amado Rafael · EVP of R&D and CMO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-09-03 | Grant or award : show line 1 in the form | +105,162 | 105,162 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-09-03 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +160,630 | 160,630 | D |
Loading xslF345X03/marketforms-45677.xml…